• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table 26Health state utility weights for people with SCI

Health statePoint estimate (QALY)95% Confidence intervalGamma distribution parametersSource
No symptomatic UTI0.8310.809–0.852α = 5707.1157
β= 0.0001
Vogel 2002 and Zebracki 2010483,529
Symptomatic UTI0.7820.764–0.799α = 7549.6790
β = 0.0001
Vogel 2002 and Zebracki 2010483,529
First-line resistant UTI0.7600.685–0.834*α = 400.0000
β = 0.0019
Expert opinion
Multidrug resistant UTI0.7380.688–0.787α = 805.6864
β = 0.0009
Vogel 2002 and Zebracki 2010483,529
Bacteraemia0.7160.645–0.786*α = 400.0000
β = 0.0018
Expert opinion
Urethral complication0.7380.688–0.787α = 805.6864
β = 0.0009
Assumed to be same as multi-drug resistant UTI
*

Estimated based on mean and standard error - intended for the purpose of clinical validation only.

Estimated based on mean and standard error - intended for the purpose of clinical validation only.

From: Appendix J, Cost-utility analysis: Intermittent self catheterisation

Cover of Infection: Prevention and Control of Healthcare-Associated Infections in Primary and Community Care
Infection: Prevention and Control of Healthcare-Associated Infections in Primary and Community Care: Partial Update of NICE Clinical Guideline 2.
NICE Clinical Guidelines, No. 139.
National Clinical Guideline Centre (UK).
Copyright © 2012, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.